Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
No Longer Available No phase listed Expanded access

Expanded Access of Sotorasib

ClinicalTrials.gov ID: NCT04667234

Public ClinicalTrials.gov record NCT04667234. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 3:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-label, Single-arm, Expanded Access Protocol of Sotorasib for the Treatment of Subjects With Previously Treated Locally Advanced Unresectable/Metastatic NSCLC With KRAS p.G12C Mutation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to provide expanded access to and characterize the safety profile of Sotorasib in participants with previously treated locally advanced/unresectable/metastatic non small-cell lung cancer (NSCLC) with KRAS p.G12C mutation in a real-world setting.

Study identification

NCT ID
NCT04667234
Recruitment status
No Longer Available
Study type
Expanded access
Phase
Not listed
Lead sponsor
Amgen
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Aug 19, 2026

United States locations

U.S. sites
30
U.S. states
21
U.S. cities
30
Facility City State ZIP Site status
Clearview Cancer Institute Huntsville Alabama 35805
Alaska Oncology and Hematology LLC Anchorage Alaska 99508
Ironwood Cancer and Research Center Chandler Arizona 85224
Arizona Oncology Associates Professional Corporation Tucson Arizona 85711
San Luis Valley Health Regional Medical Center Alamosa Colorado 81101
Kaiser Permanente Lone Tree Colorado 80124
Sacred Heart Medical Oncology Group Pensacola Florida 32504
Cancer Care Specialists of Central Illinois Decatur Illinois 62526
McFarland Clinic PC Ames Iowa 50010
Des Moines Oncology Research Association Des Moines Iowa 50309
Saint Joseph East Lexington Kentucky 40509
Louisiana Hematology Oncology Associates Baton Rouge Louisiana 70809
Northern Light Cancer Center Brewer Maine 04412
University of Pittsburgh Medical Center Western Maryland Cumberland Maryland 21502
Maryland Oncology Hematology, PA Rockville Maryland 20850
Dana Farber Cancer Institute Boston Massachusetts 02215
Mid Michigan Medical Center Midland Michigan 48640
Saint Lukes Cancer Institute Kansas City Missouri 64111
Oncology Hematology Associates Springfield Missouri 65807
Nebraska Cancer Specialists Omaha Nebraska 68130
Englewood Hospital and Medical Center Englewood New Jersey 07631
Overlook Medical Center Summit New Jersey 91010
Wake Forest Baptist Comprehensive Cancer Research Center Winston-Salem North Carolina 27157
Cleveland Clinic Taussig Cancer Institute Cleveland Ohio 44195
LeHigh Valley Hospital Allentown Pennsylvania 18103
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Scranton Hematology Oncology Scranton Pennsylvania 18510
Erlanger East Hospital Chattanooga Tennessee 37421
Baptist Cancer Center Memphis Tennessee 38120
Saint Marys Medical Center Huntington West Virginia 25705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04667234, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2026 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04667234 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →